
概要
https://www.medtronic.com/contact-us.html
ロボティクスメディアとハイライト
注目のロボティクス動画
注目のロボティクス動画はまだありません
動画はまだありません
この企業にリンクされた注目のロボティクス動画はありません。
ロボティクススナップショット
主なロボティクス分野は登録されていません。
関連ニュース

Medtronic's Hugo Robot Gets Its First FDA-Cleared Energy Instrument
Medtronic won FDA clearance for the LigaSure RAS Maryland instrument on its Hugo surgical robot, its first robotic vessel-sealing tool, though the US approval still trails what Hugo already supports internationally.

HuaKe Precision Files for STAR Market IPO with Backing from Medtronic
Beijing HuaKe Precision, the company behind the Sinovation SR1 neurosurgical robot, has filed for an IPO on the Shanghai STAR Market to raise about RMB 1 billion. The filing was accepted on June 30, setting the company up to become China's first pure-play neurosurgical robot stock. HuaKe holds a 53.3 percent share of China's neurosurgical robot market, has systems in more than 400 hospitals, and counts global device giant Medtronic as a 3.12 percent shareholder. For hospital buyers and medical device watchers, the prospectus opens a rare window into the real economics of surgical robotics in China.
関連記事

The U.S. Is No Longer the First Market a Surgical Robot Conquers
Medtronic's latest Hugo clearance covers one instrument for one U.S. specialty, four years after the platform launched abroad. Across surgical robotics, FDA clearance now proceeds one procedure at a time, and it's made the United States the last major market platforms reach with full capability.

The Surgical Robotics Shakeout: A Bankruptcy, a Duopoly Test, and the Buyer's New Leverage
Surgical robotics just lost one of its most hyped startups to bankruptcy in the same week the premium market gained its first credible second supplier in a generation. This analysis maps the consolidation economics deciding who survives, China's parallel game, and a practical evaluation framework for hospitals entering the duopoly era.
製造ロボット一覧 MEDTRONIC
経営陣
Geoff Martha (Chairman & CEO)

